The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Outsourced Drug Discovery-Global Market Insights and Sales Trends 2024
Synopsis
In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered. Historically, drugs were discovered through identifying the active ingredient from traditional remedies or by serendipitousdiscovery.
The global Outsourced Drug Discovery market size is expected to reach US$ 34250 million by 2029, growing at a CAGR of 11.1% from 2023 to 2029. The market is mainly driven by the significant applications of Outsourced Drug Discovery in various end use industries. The expanding demands from the Pharmaceutical Companies and Other, are propelling Outsourced Drug Discovery market. Chemical Services, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Biological Services segment is estimated at % CAGR for the next seven-year period.
The Drug Discovery Services market refers to the range of services provided by contract research organizations (CROs) and other service providers to support the drug discovery and development process. This market includes services such as target identification, lead optimization, preclinical testing, and clinical trial support. The Drug Discovery Services market has been experiencing significant growth due to factors such as the increasing complexity of drug development, rising outsourcing of research activities, and the need for specialized expertise. Key players in the market include CROs, pharmaceutical companies, and biotechnology firms. Geographically, the market is global, with regions witnessing a growing demand for outsourced drug discovery services.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Outsourced Drug Discovery, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Outsourced Drug Discovery market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Outsourced Drug Discovery market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Outsourced Drug Discovery sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Outsourced Drug Discovery covered in this report include IQVIA, Charles River Laboratories, Aptuit, Evotec, GenScript, PPD, WuXi AppTec and AMRI, etc.
The global Outsourced Drug Discovery market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
IQVIA
Charles River Laboratories
Aptuit
Evotec
GenScript
PPD
WuXi AppTec
AMRI
Global Outsourced Drug Discovery market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Outsourced Drug Discovery market, Segment by Type:
Chemical Services
Biological Services
Lead Optimization
Lead Identification and Screening
Global Outsourced Drug Discovery market, by Application
Pharmaceutical Companies
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Outsourced Drug Discovery companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered. Historically, drugs were discovered through identifying the active ingredient from traditional remedies or by serendipitousdiscovery.
The global Outsourced Drug Discovery market size is expected to reach US$ 34250 million by 2029, growing at a CAGR of 11.1% from 2023 to 2029. The market is mainly driven by the significant applications of Outsourced Drug Discovery in various end use industries. The expanding demands from the Pharmaceutical Companies and Other, are propelling Outsourced Drug Discovery market. Chemical Services, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Biological Services segment is estimated at % CAGR for the next seven-year period.
The Drug Discovery Services market refers to the range of services provided by contract research organizations (CROs) and other service providers to support the drug discovery and development process. This market includes services such as target identification, lead optimization, preclinical testing, and clinical trial support. The Drug Discovery Services market has been experiencing significant growth due to factors such as the increasing complexity of drug development, rising outsourcing of research activities, and the need for specialized expertise. Key players in the market include CROs, pharmaceutical companies, and biotechnology firms. Geographically, the market is global, with regions witnessing a growing demand for outsourced drug discovery services.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Outsourced Drug Discovery, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Outsourced Drug Discovery market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Outsourced Drug Discovery market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Outsourced Drug Discovery sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Outsourced Drug Discovery covered in this report include IQVIA, Charles River Laboratories, Aptuit, Evotec, GenScript, PPD, WuXi AppTec and AMRI, etc.
The global Outsourced Drug Discovery market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
IQVIA
Charles River Laboratories
Aptuit
Evotec
GenScript
PPD
WuXi AppTec
AMRI
Global Outsourced Drug Discovery market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Outsourced Drug Discovery market, Segment by Type:
Chemical Services
Biological Services
Lead Optimization
Lead Identification and Screening
Global Outsourced Drug Discovery market, by Application
Pharmaceutical Companies
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Outsourced Drug Discovery companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Outsourced Drug Discovery
1.1 Outsourced Drug Discovery Market Overview
1.1.1 Outsourced Drug Discovery Product Scope
1.1.2 Outsourced Drug Discovery Market Status and Outlook
1.2 Global Outsourced Drug Discovery Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Outsourced Drug Discovery Market Size by Region (2018-2029)
1.4 Global Outsourced Drug Discovery Historic Market Size by Region (2018-2023)
1.5 Global Outsourced Drug Discovery Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Outsourced Drug Discovery Market Size (2018-2029)
1.6.1 North America Outsourced Drug Discovery Market Size (2018-2029)
1.6.2 Europe Outsourced Drug Discovery Market Size (2018-2029)
1.6.3 Asia-Pacific Outsourced Drug Discovery Market Size (2018-2029)
1.6.4 Latin America Outsourced Drug Discovery Market Size (2018-2029)
1.6.5 Middle East & Africa Outsourced Drug Discovery Market Size (2018-2029)
2 Outsourced Drug Discovery Market by Type
2.1 Introduction
2.1.1 Chemical Services
2.1.2 Biological Services
2.1.3 Lead Optimization
2.1.4 Lead Identification and Screening
2.2 Global Outsourced Drug Discovery Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Outsourced Drug Discovery Historic Market Size by Type (2018-2023)
2.2.2 Global Outsourced Drug Discovery Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Outsourced Drug Discovery Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Outsourced Drug Discovery Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Outsourced Drug Discovery Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Outsourced Drug Discovery Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Outsourced Drug Discovery Revenue Breakdown by Type (2018-2029)
3 Outsourced Drug Discovery Market Overview by Application
3.1 Introduction
3.1.1 Pharmaceutical Companies
3.1.2 Other
3.2 Global Outsourced Drug Discovery Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Outsourced Drug Discovery Historic Market Size by Application (2018-2023)
3.2.2 Global Outsourced Drug Discovery Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Outsourced Drug Discovery Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Outsourced Drug Discovery Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Outsourced Drug Discovery Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Outsourced Drug Discovery Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Outsourced Drug Discovery Revenue Breakdown by Application (2018-2029)
4 Outsourced Drug Discovery Competition Analysis by Players
4.1 Global Outsourced Drug Discovery Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Outsourced Drug Discovery as of 2022)
4.3 Date of Key Players Enter into Outsourced Drug Discovery Market
4.4 Global Top Players Outsourced Drug Discovery Headquarters and Area Served
4.5 Key Players Outsourced Drug Discovery Product Solution and Service
4.6 Competitive Status
4.6.1 Outsourced Drug Discovery Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 IQVIA
5.1.1 IQVIA Profile
5.1.2 IQVIA Main Business
5.1.3 IQVIA Outsourced Drug Discovery Products, Services and Solutions
5.1.4 IQVIA Outsourced Drug Discovery Revenue (US$ Million) & (2018-2023)
5.1.5 IQVIA Recent Developments
5.2 Charles River Laboratories
5.2.1 Charles River Laboratories Profile
5.2.2 Charles River Laboratories Main Business
5.2.3 Charles River Laboratories Outsourced Drug Discovery Products, Services and Solutions
5.2.4 Charles River Laboratories Outsourced Drug Discovery Revenue (US$ Million) & (2018-2023)
5.2.5 Charles River Laboratories Recent Developments
5.3 Aptuit
5.3.1 Aptuit Profile
5.3.2 Aptuit Main Business
5.3.3 Aptuit Outsourced Drug Discovery Products, Services and Solutions
5.3.4 Aptuit Outsourced Drug Discovery Revenue (US$ Million) & (2018-2023)
5.3.5 Evotec Recent Developments
5.4 Evotec
5.4.1 Evotec Profile
5.4.2 Evotec Main Business
5.4.3 Evotec Outsourced Drug Discovery Products, Services and Solutions
5.4.4 Evotec Outsourced Drug Discovery Revenue (US$ Million) & (2018-2023)
5.4.5 Evotec Recent Developments
5.5 GenScript
5.5.1 GenScript Profile
5.5.2 GenScript Main Business
5.5.3 GenScript Outsourced Drug Discovery Products, Services and Solutions
5.5.4 GenScript Outsourced Drug Discovery Revenue (US$ Million) & (2018-2023)
5.5.5 GenScript Recent Developments
5.6 PPD
5.6.1 PPD Profile
5.6.2 PPD Main Business
5.6.3 PPD Outsourced Drug Discovery Products, Services and Solutions
5.6.4 PPD Outsourced Drug Discovery Revenue (US$ Million) & (2018-2023)
5.6.5 PPD Recent Developments
5.7 WuXi AppTec
5.7.1 WuXi AppTec Profile
5.7.2 WuXi AppTec Main Business
5.7.3 WuXi AppTec Outsourced Drug Discovery Products, Services and Solutions
5.7.4 WuXi AppTec Outsourced Drug Discovery Revenue (US$ Million) & (2018-2023)
5.7.5 WuXi AppTec Recent Developments
5.8 AMRI
5.8.1 AMRI Profile
5.8.2 AMRI Main Business
5.8.3 AMRI Outsourced Drug Discovery Products, Services and Solutions
5.8.4 AMRI Outsourced Drug Discovery Revenue (US$ Million) & (2018-2023)
5.8.5 AMRI Recent Developments
6 North America
6.1 North America Outsourced Drug Discovery Market Size by Country (2018-2029)
6.2 the United States
6.3 Canada
7 Europe
7.1 Europe Outsourced Drug Discovery Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Outsourced Drug Discovery Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Outsourced Drug Discovery Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Outsourced Drug Discovery Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Outsourced Drug Discovery Market Dynamics
11.1 Outsourced Drug Discovery Industry Trends
11.2 Outsourced Drug Discovery Market Drivers
11.3 Outsourced Drug Discovery Market Challenges
11.4 Outsourced Drug Discovery Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
